Prevenar 13 0.5ml Injection

Prevenar 13 0.5ml Injection is a 13-valent pneumococcal conjugate vaccine designed for active immunization against diseases caused by Streptococcus pneumoniae. This vaccine targets thirteen specific serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F), with each capsular polysaccharide antigen individually conjugated to a non-toxic diphtheria CRM197 protein. Each 0.5ml dose contains 2.2 µg of most serotypes and 4.4 µg for serotype 6B, adsorbed on aluminium phosphate.

This vaccine is indicated for the prevention of invasive pneumococcal disease, pneumonia, and acute otitis media in infants, children, and adolescents from 6 weeks to 17 years of age. It is also approved for active immunization against pneumonia and invasive disease caused by the same 13 Streptococcus pneumoniae serotypes in adults aged 18 years and older, including the elderly. The vaccine is administered intramuscularly by healthcare professionals.

Key Features : 

Provides broad protection against 13 Streptococcus pneumoniae serotypes, addressing invasive disease, pneumonia, and acute otitis media across various age groups from infants to adults.
Requires cold-chain storage between 2°C and 8°C, with strict instructions not to freeze; it remains stable for up to four days at temperatures up to 25°C for temporary excursions.
Administered via intramuscular injection, with specific dosing schedules varying by age, including multi-dose primary series for infants and single doses for older children and adults.
Holds regulatory approvals from authorities such as the European Union (EU), United States (US) FDA, and the Australian Register of Therapeutic Goods (ARTG), and has received WHO prequalification for various age indications.

Each 0.5 ml dose of Prevenar 13 Injection contains purified capsular polysaccharides from 13 pneumococcal serotypes conjugated to a carrier protein. This enhances immune response and provides long-lasting protection for infants, children, and adults. The vaccine also contains an aluminum-based adjuvant and stabilizers to maintain potency and safety, in accordance with WHO and regulatory guidelines.

1. Clean a 2-inch area around the injection site (upper arm/deltoid muscle) with an alcohol swab.
2. Prepare and draw the vaccine into a sterile syringe.
3. Insert the needle at a 90° angle into the muscle and administer quickly.
4. Withdraw the needle at the same angle and press a cotton swab at the site.

Note: Do not self-administer. This injection should only be given by a qualified healthcare professional.

• For use only under medical supervision and valid prescription.
• Avoid in individuals with a history of severe allergic reactions to any vaccine component.
• May cause mild side effects such as injection site pain, fever, or drowsiness.
• Not recommended for pregnant or breastfeeding women unless prescribed by a physician.
• Patients should be monitored briefly after injection for adverse reactions.